220 related articles for article (PubMed ID: 34326322)
1. An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer.
Das R; Sjöström M; Shrestha R; Yogodzinski C; Egusa EA; Chesner LN; Chen WS; Chou J; Dang DK; Swinderman JT; Ge A; Hua JT; Kabir S; Quigley DA; Small EJ; Ashworth A; Feng FY; Gilbert LA
Nat Commun; 2021 Jul; 12(1):4601. PubMed ID: 34326322
[TBL] [Abstract][Full Text] [Related]
2. KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.
Chen J; Zhao CC; Chen FR; Feng GW; Luo F; Jiang T
Biomed Res Int; 2021; 2021():8249293. PubMed ID: 34805404
[TBL] [Abstract][Full Text] [Related]
3. DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway.
Kothari V; Goodwin JF; Zhao SG; Drake JM; Yin Y; Chang SL; Evans JR; Wilder-Romans K; Gabbara K; Dylgjeri E; Chou J; Sun G; Tomlins SA; Mehra R; Hege K; Filvaroff EH; Schaeffer EM; Karnes RJ; Quigley DA; Rathkopf DE; He HH; Speers C; Spratt DE; Gilbert LA; Ashworth A; Chinnaiyan AM; Raj GV; Knudsen KE; Feng FY
Clin Cancer Res; 2019 Sep; 25(18):5608-5622. PubMed ID: 31266829
[TBL] [Abstract][Full Text] [Related]
4. ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
Centenera MM; Scott JS; Machiels J; Nassar ZD; Miller DC; Zinonos I; Dehairs J; Burvenich IJG; Zadra G; Chetta PM; Bango C; Evergren E; Ryan NK; Gillis JL; Mah CY; Tieu T; Hanson AR; Carelli R; Bloch K; Panagopoulos V; Waelkens E; Derua R; Williams ED; Evdokiou A; Cifuentes-Rius A; Voelcker NH; Mills IG; Tilley WD; Scott AM; Loda M; Selth LA; Swinnen JV; Butler LM
Cancer Res; 2021 Apr; 81(7):1704-1718. PubMed ID: 33547161
[TBL] [Abstract][Full Text] [Related]
5. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
[TBL] [Abstract][Full Text] [Related]
6. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
Singh R; Karri D; Shen H; Shao J; Dasgupta S; Huang S; Edwards DP; Ittmann MM; O'Malley BW; Yi P
J Clin Invest; 2018 Jul; 128(7):3129-3143. PubMed ID: 29715200
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
[TBL] [Abstract][Full Text] [Related]
8. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.
Sawada Y; Kikugawa T; Iio H; Sakakibara I; Yoshida S; Ikedo A; Yanagihara Y; Saeki N; Győrffy B; Kishida T; Okubo Y; Nakamura Y; Miyagi Y; Saika T; Imai Y
Int J Cancer; 2020 Mar; 146(5):1369-1382. PubMed ID: 31276604
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells.
Kawamura N; Nimura K; Nagano H; Yamaguchi S; Nonomura N; Kaneda Y
Oncotarget; 2015 Sep; 6(26):22361-74. PubMed ID: 26087476
[TBL] [Abstract][Full Text] [Related]
10. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
[TBL] [Abstract][Full Text] [Related]
11. Plectin is a regulator of prostate cancer growth and metastasis.
Buckup M; Rice MA; Hsu EC; Garcia-Marques F; Liu S; Aslan M; Bermudez A; Huang J; Pitteri SJ; Stoyanova T
Oncogene; 2021 Jan; 40(3):663-676. PubMed ID: 33219316
[TBL] [Abstract][Full Text] [Related]
12. Kinesin 12 (KIF15) contributes to the development and tumorigenicity of prostate cancer.
Qureshi Z; Ahmad M; Yang WX; Tan FQ
Biochem Biophys Res Commun; 2021 Oct; 576():7-14. PubMed ID: 34474246
[TBL] [Abstract][Full Text] [Related]
13. KIF4A: A potential biomarker for prediction and prognostic of prostate cancer.
Chen J; Li M; Fang S; Zhou X; Liao J; Yang S; Zhu J; He R; Lu J; Jiang F; Xu X; Zhong W
Clin Invest Med; 2020 Sep; 43(3):E49-59. PubMed ID: 32971585
[TBL] [Abstract][Full Text] [Related]
14. Dietary Fructose Promotes Prostate Cancer Growth.
Carreño DV; Corro NB; Cerda-Infante JF; Echeverría CE; Asencio-Barría CA; Torres-Estay VA; Mayorga-Weber GA; Rojas PA; Véliz LP; Cisternas PA; Montecinos VP; San Francisco IF; Varas-Godoy MA; Sotomayor PC; Castro MA; Nualart FJ; Inestrosa NC; Godoy AS
Cancer Res; 2021 Jun; 81(11):2824-2832. PubMed ID: 33762358
[TBL] [Abstract][Full Text] [Related]
15. Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer.
Vainio P; Wolf M; Edgren H; He T; Kohonen P; Mpindi JP; Smit F; Verhaegh G; Schalken J; Perälä M; Iljin K; Kallioniemi O
Prostate; 2012 May; 72(7):789-802. PubMed ID: 21919029
[TBL] [Abstract][Full Text] [Related]
16. An
Lu X; Pan X; Wu CJ; Zhao D; Feng S; Zang Y; Lee R; Khadka S; Amin SB; Jin EJ; Shang X; Deng P; Luo Y; Morgenlander WR; Weinrich J; Lu X; Jiang S; Chang Q; Navone NM; Troncoso P; DePinho RA; Wang YA
Cancer Res; 2018 Jul; 78(14):3823-3833. PubMed ID: 29769196
[TBL] [Abstract][Full Text] [Related]
17. An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression.
Scheidmann MC; Castro-Giner F; Strittmatter K; Krol I; Paasinen-Sohns A; Scherrer R; Donato C; Gkountela S; Szczerba BM; Diamantopoulou Z; Muenst S; Vlajnic T; Kunz L; Vetter M; Rochlitz C; Taylor V; Giachino C; Schroeder T; Platt RJ; Aceto N
Cancer Res; 2022 Feb; 82(4):681-694. PubMed ID: 34916221
[TBL] [Abstract][Full Text] [Related]
18. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
[TBL] [Abstract][Full Text] [Related]
19. Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis.
Wu Z; Cho H; Hampton GM; Theodorescu D
Neoplasia; 2009 Jan; 11(1):66-76. PubMed ID: 19107233
[TBL] [Abstract][Full Text] [Related]
20. CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.
Dalton GN; Massillo C; Scalise GD; Duca R; Porretti J; Farré PL; Gardner K; Paez A; Gueron G; De Luca P; De Siervi A
Cell Death Dis; 2019 Apr; 10(4):299. PubMed ID: 30931931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
